Official UK procurement notice
Total Cellular Pathology Solution · ROCHE DIAGNOSTICS LIMITED for Business Services Organisation (Apr 2024)
Authority: Business Services Organisation
Sectors: Medical Devices & Pharma (33) Delivery: Northern Ireland (UKN)
Awarded value£8,121,573published contract · exc. VAT
Awarded 2 Apr 2015
Awarded to ROCHE DIAGNOSTICS LIMITED
Contract term Ends 30 Jun 2024
What is being bought
Published requirement descriptionNo description was published on the notice. See the official documents.
CPV: Diagnostic systems
The lotProcurement structure
single lot · no lot value publishedLot #1Total Cellular Pathology Solution
Procedure terms & legal framework
From the official record- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Competitive procedure
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- Unspecified in notice
- First published
- 16 Apr 2024, 12:54 BST
- Last source update
- 16 Apr 2024, 12:54 BST
- Authority reference
14996- FTS notice number
2024/S 000-012334- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-04529fFind a Tender
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecastAwards 1
Awarded value £8,121,5731 contract exc. VAT
Contracts signed 1latest 2 Apr 2015
| Awarded to | Value | Date | Status |
|---|---|---|---|
| ROCHE DIAGNOSTICS LIMITED | £8,121,573 † | — | Awarded |
Contracts
Contract 012334-2024-14996-1 · ROCHE DIAGNOSTICS LIMITED
- Signed
- 2 Apr 2015
- Value
- £8,121,573
- Period
- … – 30 Jun 2024
- Status
- active
- Change Extension of existing contract from end date 30th June 2024 to 31st December 2024. We wish also to have the option to extend for up to a further 6 months in 6 x 1 month periods beyond the new expiry date of 31st December 2024 should extension become necessary., Need for modification brought about by circumstances which a diligent contracting authority/entity could not foresee: A regional renewal tender process to replace this contract is currently under evaluation and is undergoing financial scrutiny. The extension request to existing contract, ref 14996, is required to ensure ongoing service delivery until new contract award and implementation. This extension is being conducted in line with Reg 72(1)(c) of the 2015 PCR.
Contracting authority & participating public bodies
Dispute resolution & review bodies
- Business Services Organsiation, PaLSReview body
Bidders & participating suppliers
1 commercial party on the notice- Roche Diagnostics LtdAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.